MU INVESTOR DEADLINE: Micron Technology, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
San Diego, California--(Newsfile Corp. - March 1, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Micron Technology, Inc. (NASDAQ: MU) common stock between September 28, 2023 and December 18, 2024, both dates inclusive (the "Class Period"), have until Monday, March 10, 2025 to seek appointment as lead plaintiff of the Micron class action lawsuit. Captioned Klein v. Micron Technology, Inc., No. 25-cv-80040 (S.D. Fla.), the Micron class action lawsuit charges...
2025-03-01 9:40 AM EST
TTD INVESTOR DEADLINE: The Trade Desk, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
San Diego, California--(Newsfile Corp. - February 26, 2025) - The law firm Robbins Geller Rudman & Dowd LLP announces that purchasers of The Trade Desk, Inc. (NASDAQ: TTD) Class A common stock between May 9, 2024 and February 12, 2025, both dates inclusive (the "Class Period"), have until April 21, 2025 to seek appointment as lead plaintiff of the Trade Desk class action lawsuit. Captioned United Union of Roofers, Waterproofers & Allied Workers Local Union No. 8 WBPA Fund v. The Trade Desk,...
2025-02-26 8:15 PM EST
NMRA INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
San Diego, California--(Newsfile Corp. - February 25, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Neumora Therapeutics, Inc. (NASDAQ: NMRA) common stock pursuant and/or traceable to Neumora's registration statement issued in connection with Neumora's initial public offering (the "IPO") held on September 15, 2023, have until Monday, April 7, 2025 to seek appointment as lead plaintiff of the Neumora class action lawsuit. Captioned Chang v....
2025-02-25 11:10 AM EST
MERCK INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MRK
San Diego, California--(Newsfile Corp. - February 24, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Merck & Co., Inc. (NYSE: MRK) securities between February 3, 2022 and February 3, 2025, inclusive (the "Class Period"), have until Monday, April 14, 2025 to seek appointment as lead plaintiff of the Merck class action lawsuit. Captioned Cronin v. Merck & Co., Inc., No. 25-cv-01208 (D.N.J.), the Merck class action lawsuit charges Merck and certain of Merck's...
2025-02-24 2:10 PM EST
ICLR INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that ICON PLC Investors with Substantial Losses Have Opportunity to Lead the Class Action Lawsuit
San Diego, California--(Newsfile Corp. - February 23, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers of ICON PLC (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, all dates inclusive (the "Class Period"), have until April 11, 2025 to seek appointment as lead plaintiff of the ICON class action lawsuit. Captioned Shing v. ICON plc, No. 25-cv-00763 (E.D.N.Y.), the ICON class action lawsuit charges ICON as well as certain of ICON's top executive...
2025-02-23 6:11 PM EST
TRANSMEDICS INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TMDX
San Diego, California--(Newsfile Corp. - February 23, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of TransMedics Group, Inc. (NASDAQ: TMDX) publicly traded securities between February 28, 2023 and January 10, 2025, inclusive (the "Class Period"), have until April 15, 2025 to seek appointment as lead plaintiff of the TransMedics class action lawsuit. Captioned Jewik v. TransMedics Group, Inc., No. 25-cv-10385 (D. Mass.), the TransMedics class action lawsuit...
2025-02-23 2:10 PM EST
INVESTOR DEADLINE MONDAY: Transocean Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RIG
San Diego, California--(Newsfile Corp. - February 20, 2025) - Robbins Geller Rudman & Dowd LLP announces that the Transocean class action lawsuit — captioned Gábor v. Transocean Ltd., No. 24-cv-09964 (S.D.N.Y.) — charges Transocean Ltd. (NYSE: RIG) as well as certain of Transocean's top current and former executives with violations of the Securities Exchange Act of 1934. A subsequently-filed complaint is captioned Matteson v. Transocean Ltd., No. 25-cv-01112 (S.D.N.Y.). If you suffered...
2025-02-20 5:30 PM EST
ICLR INVESTOR DEADLINE: ICON PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
San Diego, California--(Newsfile Corp. - February 20, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of ICON PLC (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the "Class Period"), have until April 11, 2025 to seek appointment as lead plaintiff of the ICON class action lawsuit. Captioned Shing v. ICON plc, No. 25-cv-00763 (E.D.N.Y.), the ICON class action lawsuit charges ICON as well as certain of ICON's top executive...
2025-02-20 4:08 PM EST
MRK INVESTOR DEADLINE: Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
San Diego, California--(Newsfile Corp. - February 20, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Merck & Co., Inc. (NYSE: MRK) securities between February 3, 2022 and February 3, 2025, inclusive (the "Class Period"), have until April 14, 2025 to seek appointment as lead plaintiff of the Merck class action lawsuit. Captioned Cronin v. Merck & Co., Inc., No. 25-cv-01208 (D.N.J.), the Merck class action lawsuit charges Merck as well as...
2025-02-20 11:25 AM EST
ESTC INVESTOR DEADLINE: Elastic N.V. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
San Diego, California--(Newsfile Corp. - February 20, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Elastic N.V. (NYSE: ESTC) securities between May 31, 2024 and August 29, 2024, both dates inclusive (the "Class Period"), have until April 14, 2025 to seek appointment as lead plaintiff of the Elastic class action lawsuit. Captioned Lucid Alternative Fund, LP v. Elastic N.V., No. 25-cv-00785 (E.D.N.Y.), the Elastic class action lawsuit...
2025-02-20 9:20 AM EST
MPWR INVESTOR NOTICE: Monolithic Power Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
San Diego, California--(Newsfile Corp. - February 19, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers of Monolithic Power Systems, Inc. (NASDAQ: MPWR) common stock between February 8, 2024 and November 8, 2024, all dates inclusive (the "Class Period"), have until April 7, 2025 to seek appointment as lead plaintiff of the Monolithic Power Systems class action lawsuit. Captioned Waterford Township General Employees Retirement System v. Monolithic Power Systems, Inc., No....
2025-02-19 5:35 PM EST
NEM INVESTOR NOTICE: Newmont Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
San Diego, California--(Newsfile Corp. - February 19, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Newmont Corporation (NYSE: NEM) securities between February 22, 2024 and October 23, 2024, inclusive (the "Class Period"), have until Tuesday, April 1, 2025 to seek appointment as lead plaintiff of the Newmont class action lawsuit. Captioned Karas v. Newmont Corporation, No. 25-cv-00341 (D. Colo.), the Newmont class action lawsuit charges Newmont and certain...
2025-02-19 9:23 AM EST
TMDX INVESTOR DEADLINE: TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
San Diego, California--(Newsfile Corp. - February 18, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of TransMedics Group, Inc. (NASDAQ: TMDX) publicly traded securities between February 28, 2023 and January 10, 2025, both dates inclusive (the "Class Period"), have until April 15, 2025 to seek appointment as lead plaintiff of the TransMedics class action lawsuit. Captioned Jewik v. TransMedics Group, Inc., No. 25-cv-10385 (D. Mass.), the TransMedics class...
2025-02-18 1:10 PM EST
BIOA INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
San Diego, California--(Newsfile Corp. - February 18, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of BioAge Labs, Inc. (NASDAQ: BIOA) stock pursuant and/or traceable to BioAge Labs' registration statement issued in connection with BioAge Labs' initial public offering ("IPO") held on September 26, 2024, have until Monday, March 10, 2025 to seek appointment as lead plaintiff of the BioAge Labs class action lawsuit. Captioned Soto v. BioAge Labs, Inc., No....
2025-02-18 11:45 AM EST
WBA INVESTOR NOTICE: Walgreens Boots Alliance, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
San Diego, California--(Newsfile Corp. - February 17, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) common stock between April 2, 2020 and January 16, 2025, inclusive (the "Class Period"), have until Monday, March 31, 2025 to seek appointment as lead plaintiff of the Walgreens class action lawsuit. Captioned Klein v. Walgreens Boots Alliance, Inc., No. 25-cv-01058 (N.D. Ill.), the Walgreens class action lawsuit...
2025-02-17 2:00 PM EST
NMRA INVESTOR DEADLINE: Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
San Diego, California--(Newsfile Corp. - February 17, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Neumora Therapeutics, Inc. (NASDAQ: NMRA) common stock pursuant and/or traceable to Neumora's registration statement issued in connection with Neumora's initial public offering (the "IPO") held on September 15, 2023, have until April 7, 2025 to seek appointment as lead plaintiff of the Neumora class action lawsuit. Captioned Chang v. Neumora...
2025-02-17 12:15 PM EST
INVESTOR DEADLINE APPROACHING: Nextracker Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - NXT
San Diego, California--(Newsfile Corp. - February 17, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers of Nextracker Inc. (NASDAQ: NXT) common stock between February 1, 2024 and August 1, 2024, both dates inclusive (the "Class Period"), have until Tuesday, February 25, 2025 to seek appointment as lead plaintiff of the Nextracker class action lawsuit. Captioned Weber v. Nextracker Inc., No. 24-cv-09467 (N.D. Cal.), the Nextracker class action lawsuit charges Nextracker as...
2025-02-17 7:50 AM EST
MODV INVESTOR NOTICE: ModivCare, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
San Diego, California--(Newsfile Corp. - February 16, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that the ModivCare class action lawsuit – captioned Kalera v. ModivCare, Inc., No. 25-cv-00306, and pending in the District of Colorado – charges ModivCare, Inc. (NASDAQ: MODV) and certain of ModivCare's executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the ModivCare class action...
2025-02-16 10:13 AM EST
INVESTOR DEADLINE TUESDAY: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - APLT
San Diego, California--(Newsfile Corp. - February 14, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), have until this Tuesday, February 18, 2025 to seek appointment as lead plaintiff of the Applied Therapeutics class action lawsuit. Captioned Alexandru v. Applied Therapeutics, Inc., No. 24-cv-09715 (S.D.N.Y.), the...
2025-02-14 10:45 PM EST
NVO INVESTOR DEADLINE: Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
San Diego, California--(Newsfile Corp. - February 12, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Novo Nordisk A/S (NYSE: NVO) securities between November 2, 2022 and December 19, 2024, inclusive (the "Class Period"), have until Tuesday, March 25, 2025 to seek appointment as lead plaintiff of the Novo Nordisk class action lawsuit. Captioned Moon v. Novo Nordisk A/S, No. 25-cv-00713 (D.N.J.), the Novo Nordisk class action lawsuit charges...
2025-02-12 12:00 PM EST